A major clinical trial reveals no significant difference in 1-year DMEK graft success rates between...
Author - Hippocrates Briefs Team
STELLAR-303 Trial: Redefining Treatment for Refractory...
The STELLAR-303 trial shows zanzalintinib plus atezolizumab significantly improves overall survival...
Personalizing Colon Cancer Treatment: The Role of Circulating...
The DYNAMIC-III trial reveals how ctDNA-guided adjuvant therapy impacts recurrence-free survival...
RBM20 ASOs: A Novel Therapeutic Approach for HFpEF Diastolic...
Discover how RBM20 antisense oligonucleotides alleviate diastolic dysfunction in a mouse model of...
Beyond Traditional Risk Factors: VAT and Hepatic Fat’s...
Explore how visceral adipose tissue and hepatic fat independently influence carotid...
Innovating Stroke Research: Integrating AI, Platform, and...
Explore the opportunities and challenges of integrating artificial intelligence and novel trial...
RZV Shows High, Consistent Protection for Immunocompromised and...
A new study evaluating the recombinant herpes zoster vaccine (RZV) in the Medicare population...
Two-in-One Protection: Evaluating the Trivalent Salmonella...
A new study evaluating a Trivalent Salmonella Conjugate Vaccine (TSCV) confirms its safety and...
Delayed Diagnosis and Greater Disability: The Impact of ADHD on...
A new study evaluating sex differences in adult Attention-Deficit/Hyperactivity Disorder (ADHD)...
Nanobody Therapy for PsA: SLK Safety and Efficacy Data from a...
A novel nanobody targeting the inflammatory IL-17 pathway has shown remarkable efficacy in patients...